Izrael - angličtina - Ministry of Health

abbott medical laboratories ltd, israel - a/darwin/9/2021 (h3n2)-like virus; a/victoria/4897/2022 (h1n1)pdm09-like virus; b/austria/1359417/2021 (b/victoria lineage)-like virus; b/phuket/3073/2013 (b/yamagata lineage)-like virus - suspension for injection - b/phuket/3073/2013 (b/yamagata lineage)-like virus 30 mcg ha / 1 ml; a/darwin/9/2021 (h3n2)-like virus 30 mcg ha / 1 ml; b/austria/1359417/2021 (b/victoria lineage)-like virus 30 mcg ha / 1 ml; a/victoria/4897/2022 (h1n1)pdm09-like virus 30 mcg ha / 1 ml - influenza, inactivated, split virus or surface antigen - prophylaxis of influenza, especially those who run an increased risk of associated complications. influvac tetra is indicated in adults and children from 6 months of age.

Malajzia - angličtina - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

abbott laboratories (m) sdn. bhd. - inactivated,influenza virus type a (h1n1); inactivated,influenza virus type a (h3n2); inactivated,influenza virus type b (b/yamagata); inactivated,influenza virus type b (b/victoria) -

Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

viatris limited - influenza virus a/michigan/45/2015 (h1n1) pdm09 - like strain 15ug (a/singapore/gp1908/2015, ivr-180); influenza virus a/singapore/infimh-16-0019/2016 (h3n2) - like strain 15ug (a/singapore/infimh-16-0019/2016, nib-104); influenza virus b/phuket/3073/2013 - like strain 15ug (b/phuket/3073/2013, wild type) - suspension for injection - 0.5 ml - active: influenza virus a/michigan/45/2015 (h1n1) pdm09 - like strain 15ug (a/singapore/gp1908/2015, ivr-180) influenza virus a/singapore/infimh-16-0019/2016 (h3n2) - like strain 15ug (a/singapore/infimh-16-0019/2016, nib-104) influenza virus b/phuket/3073/2013 - like strain 15ug (b/phuket/3073/2013, wild type) excipient: calcium chloride dihydrate dibasic sodium phosphate dihydrate magnesium chloride hexahydrate monobasic potassium phosphate potassium chloride sodium chloride water for injection - for the prevention of influenza virus, types a and b in adults and children older than 6 months in accordance with the recommendations in the national immunisation guideline.

Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

viatris limited - influenza virus a (h1n1) haemagglutinin 15ug (a/victoria/4897/2022 (h1n1) pdm09-like strain (a/victoria/4897/2022, ivr-238)); influenza virus a (h3n2) haemagglutinin 15ug (a/thailand/8/2022 (h3n2)-like strain (a/thailand/8/2022, ivr-237)); influenza virus b (victoria) haemagglutinin 15ug (b/austria/1359417/2021-like strain (b/austria/1359417/2021, bvr-26)); influenza virus b (yamagata) haemagglutinin 15ug (b/phuket/3073/2013-like strain (b/phuket/3073/2013, wild type)) - suspension for injection - 0.5 ml - active: influenza virus a (h1n1) haemagglutinin 15ug (a/victoria/4897/2022 (h1n1) pdm09-like strain (a/victoria/4897/2022, ivr-238)) influenza virus a (h3n2) haemagglutinin 15ug (a/thailand/8/2022 (h3n2)-like strain (a/thailand/8/2022, ivr-237)) influenza virus b (victoria) haemagglutinin 15ug (b/austria/1359417/2021-like strain (b/austria/1359417/2021, bvr-26)) influenza virus b (yamagata) haemagglutinin 15ug (b/phuket/3073/2013-like strain (b/phuket/3073/2013, wild type)) excipient: calcium chloride dihydrate dibasic sodium phosphate as dihydrate 0.67 mg magnesium chloride hexahydrate monobasic potassium phosphate potassium chloride sodium chloride water for injection - for the prevention of influenza caused by influenza virus, types a and b. for full details regarding recommendations for influenza vaccination, please refer to the relevant national immunisation guidelines. influvac tetra is indicated in adults and children from 6 months of age and older.

Izrael - angličtina - Ministry of Health

abbott medical laboratories ltd, israel - a/cambodia/e0826360/2020 (h3n2)-like strain; a/victoria/2570/2019 (h1n1)pdm09-like strain; b/washington/02/2019 (b/victoria lineage)-like virus - suspension for injection - b/washington/02/2019 (b/victoria lineage)-like virus 15 mcg/dose / 0.5 ml; a/cambodia/e0826360/2020 (h3n2)-like strain 15 mcg / 0.5 ml; a/victoria/2570/2019 (h1n1)pdm09-like strain 15 mcg / 0.5 ml - influenza, inactivated, split virus or surface antigen - influenza, inactivated, whole virus - influenza virus vaccine.

Singapur - angličtina - HSA (Health Sciences Authority)

abbott laboratories (singapore ) private limited - influenza virus (sh) a/thailand/8/2022 (h3n2)-like strain (a/thailand/8/2022, ivr-237); influenza virus (sh) a/victoria/4897/2022 (h1n1)pdm09-like strain (a/victoria/4897/2022, ivr-238); influenza virus (sh) b/austria/1359417/2021-like strain (b/austria/1359417/2021, bvr-26) - injection, suspension - 15mcg haemagglutinin/0.5ml - influenza virus (sh) a/thailand/8/2022 (h3n2)-like strain (a/thailand/8/2022, ivr-237) 15mcg ha/0.5ml; influenza virus (sh) a/victoria/4897/2022 (h1n1)pdm09-like strain (a/victoria/4897/2022, ivr-238) 15mcg ha/0.5 ml; influenza virus (sh) b/austria/1359417/2021-like strain (b/austria/1359417/2021, bvr-26) 15mcg ha/0.5ml

Írsko - angličtina - HPRA (Health Products Regulatory Authority)

bgp products ltd - a/california/7/2009 (h1n1)pdm09-like strain (a/california/7/2009, x-181), a/hong kong/4801/2014 (h3n2) - like strain (a/hong kong/4801/2014, nymc x-263b), b/brisbane/60/2008 - like strain (b/brisbane/60/2008) - suspension for injection - 0.5 microgram - influenza vaccines

Írsko - angličtina - HPRA (Health Products Regulatory Authority)

mylan products limited - a/california/7/2009 (h1n1)pdm09-like strain (a/california/7/2009, x-181), a/hong kong/4801/2014 (h3n2) - like strain (a/hong kong/4801/2014, nymc x-263b), b/brisbane/60/2008 - like strain (b/brisbane/60/2008) - suspension for injection - 0.5 microgram - influenza vaccines

Arménsko - angličtina - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

abbott biologicals b.v. veerweg 12 - influenza vaccine inactivated (surface antigen)-a/brisbane/02/2018 (h1n1) pdm-like strain (a/brisbane/02/2018, ivr-190), a/kansas/14/2017 (h3n2)-like strain (a/ a/kansas/14/2017, nymc x-327), b/colorado/06/2017-like strain (b/ victoria/2/87/ lineage) (b/maryland/15/2016, nymc bx-69 a) - suspension for injection - 15mcg haemagglutinin/dose+ 15mcg haemagglutinin/dose+ 15mcg haemagglutinin/dose

Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

viatris limited - influenza virus a/brisbane/02/2018 (h1n1) pdm09-like strain 15ug (a/brisbane/02/2018, ivr-190); influenza virus a/kansas/14/2017 (h3n2) like strain 15ug (a/kansas/14/2017, nymc x-327); influenza virus b/colorado/06/2017 - like strain 15ug (b/maryland/15/2016, nymc bx-69a); influenza virus b/phuket/3073/2013 - like strain 15ug (b/ phuket/3073/2013, wild type) - suspension for injection - 0.5 ml - active: influenza virus a/brisbane/02/2018 (h1n1) pdm09-like strain 15ug (a/brisbane/02/2018, ivr-190) influenza virus a/kansas/14/2017 (h3n2) like strain 15ug (a/kansas/14/2017, nymc x-327) influenza virus b/colorado/06/2017 - like strain 15ug (b/maryland/15/2016, nymc bx-69a) influenza virus b/phuket/3073/2013 - like strain 15ug (b/ phuket/3073/2013, wild type) excipient: calcium chloride dihydrate dibasic sodium phosphate as dihydrate 0.67 mg magnesium chloride hexahydrate monobasic potassium phosphate potassium chloride sodium chloride water for injection - for the prevention of influenza caused by influenza virus, types a and b. for full details regarding recommendations for influenza vaccination, please refer to the relevant national immunisation guidelines. influvac tetra (saison 2019/2020) is indicated in adults and children 3 years of age and older at low risk of complications from influenza.